The plasma homocysteine concentrations and prior myocardial infarction

Lucia Agoşton-Coldea1, Teodora Mocan, Andrada Seicean

  • 1Department of Medical Sciences, Iuliu Haţieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. luciacoldea@yahoo.com

Insights

Elevated plasma homocysteine levels predict cardiovascular events and correlate with coronary artery disease severity. This study suggests homocysteine as a valuable clinical marker for cardiovascular risk assessment.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Elevated plasma homocysteine is linked to vascular disease and cardiovascular event risk.
  • Homocysteine levels may correlate with disease severity in patients with coronary artery disease.

Purpose of the Study:

  • To analyze the relationship between homocysteine concentrations and coronary artery disease (CAD) progression.
  • To evaluate homocysteine as a predictor of cardiovascular events in patients with prior myocardial infarction.

Main Methods:

  • A study involving 208 patients, divided into those with prior myocardial infarction (n=104) and a control group without coronary artery disease (n=104).
  • Plasma homocysteine levels were measured and analyzed in relation to cardiovascular risk factors and disease presence.

Main Results:

  • Patients with prior myocardial infarction exhibited significantly higher mean plasma homocysteine levels compared to controls (18.98 ± 4.72 vs. 14.09 ± 3.32 µmol/L, p < 0.001).
  • Multivariate analysis identified homocysteine >15 µmol/L as an independent cardiovascular risk factor (OR 2.05; 95% CI 1.56-2.54).
  • Receiver Operator Curve analysis indicated good reliability for homocysteine in diagnosing coronary artery disease (AUC = 0.671, p < 0.001).

Conclusions:

  • A positive correlation was observed between plasma homocysteine levels and the severity of coronary lesions (r = 0.765, p < 0.005).
  • The findings support the use of plasma homocysteine as a clinical marker for cardiovascular risk assessment.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...